UMC Utrecht

STOPSTORM External Advisory Board

External Advisory Board Members uitklapper, klik om te openen

Prof. Clifford Robinson, MD

Prof. Clifford Robinson, MD is a Radiation Oncologist, Chief of the Stereotactic Body Radiation Therapy (SBRT) and Director of Clinical Trials for Radiation Oncology at Washington University St. Louis, United States of America. He is also a Pioneer in the application of SBRT to treat arrhythmias in the USA.


Phillip Cuculich, MD

Phillip Cuculich, MD is a Cardiologist at Washington University St. Louis, United States of America. He is specialized in arrhythmias, sudden cardiac death, atrial fibrillation, ventricular tachycardia, inherited (genetic) disorders of the heart. He is also a pioneer in the application of SBRT to treat arrhythmias in the USA.

Dr. Matthew Bates, MD

Dr. Matthew Bates, MD is a Cardiologist / Electrophysiologist at South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough, United Kingdom. He is accredited in all aspects of cardiac rhythm management including complex cardiac devices and ablation for atrial fibrillation and ventricular tachycardia. He is also a Founding member of SABR VT Ablation Consortium in the UK

Prof. Matthew Hatton, MD

Prof. Matthew Hatton, MD is a Radiation Oncologist at Sheffield Teaching Hospitals NHS Foundation Trust, University of Sheffield, United Kingdom. His research interests include functional imaging for radiotherapy planning and novel radiotherapy fractionations. He is an expert in stereotactic ablation body radiotherapy (SABR) for treatment of lung cancer.

Dr. Paul Zei, MD

Dr. Paul Zei, MD is a Cardiac Electrophysiologist and Cardiologist at Brigham and Women’s Hospital, Harvard University, Boston, United States of America. He is also the Director of the Comprehensive Atrial Fibrillation Program. Expert in the management of complex arrhythmias, with an emphasis on atrial fibrillation, catheter ablation of complex arrhythmias, and device implantation.


EU flag

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 945119. Follow us on Twitter and Linkedin.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

This website uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not